PPT-Addendum: INITIATION AND CLINICAL MANAGEMENT OF ORAL PrEP

Addendum INITIATION AND CLINICAL MANAGEMENT OF ORAL PrEP Note AGYW should follow the same procedures for initiation followup and maintenance as adults This has been provided as an optional module. Dr.. Rachel Baggaley, HIV dept. WHO, Geneva. GNP+ . WEBINAR: What does PrEP mean for. people living with HIV: science, policy. and . implementation?. . Date: Thursday, 30th July 2015. Time: 4pm CET. 4. . (a) . Getting . started on . PrEP. Session overview. Screening. Initiation. Follow up and maintenance . Clinical management . (integrated session with modules 4b – 4g). Risks and side effects. Alexis R. Santos Lozada, MA. Diego Caraballo. Jos. é N. Caraballo, PhD. Introduction . Human Papillomavirus is one of the most common sexually transmitted infections in the United States.. This infection has been catalogued as a requirement for the development of cervical cancer later in life.. PrEP. Note: . AGYW should follow the same procedures for initiation, follow-up, and maintenance as adults. This has been provided as an optional module.. Version. : December . 2018. Outline of training. PrEP. Version. : December . 2018. Outline of training. Module 1: Introduction to oral PrEP. Oral PrEP: the basics. What is combination prevention?. How effective is oral PrEP? . What are the differences among PrEP, PEP, and ART? . PrEP. Note: . AGYW should follow the same procedures for initiation, follow-up, and maintenance as adults. This has been provided as an optional module.. Version: August 2018. Outline of training. Module 1: Introduction to oral PrEP. PrEP. . IN THE CONTEXT OF AGYW . Version: August 2018. Outline of training. Module 1: Introduction to oral PrEP. PrEP: the basics. What is combination prevention?. How effective is oral PrEP? . What are the differences among PrEP, PEP, and ART? . Knowledge Just over three-quarters of providers were familiar with oral PrEP, while 23% had not heard of it (Figure 2). The most common sources of information were the national guidelines/policy and other healthcare workers. Zindoga. Mukandavire. 1. , . Graham F. Medley. 1. , Fern Terris-Prestholt. 1. ,. . Daniel J. Klein. 2. , Anna Bershteyn. 2. , Katharine Kripke. 3. , Joseph Murungu. 4. , . Definate. Nhamo. 4. ,. . MB -to RRSP Contract01161of 4ManitobaLocked-in Retirement Account LIRA Addendum To RRSP ContractTHIS IS AN ADDENDUM TO AN RRSP CONTRACT BETWEENthe OwnerANDCOMPUTERSHARE TRUST COMPANY OF CANADA the Iss U. sers. . W. ho. Test Positive for HIV. Jean-Michel Molina, . MD. University . of . Paris and . Saint-Louis . Hospital, INSERM U944, France. HIV testing and Management in the Era of PrEP. Disclosures. Facilitator Background Materials. Review these slides prior to using these materials. Introduction to Training Materials. These training materials . May need to be modified for use if national guidelines do not align with WHO guidance as of March 2022. Basics of Injectable Cabotegravir. for HIV Prevention . Draft for Comment . AVAC. March 2022. Outline. What is cabotegravir (CAB)? . Treatment . Prevention . Clinical research. What users think . Regulatory and guidelines. Promote Sexual Health. www.hivguidelines.org. MAY 2022. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Increase awareness and knowledge of . PrEP. efficacy among clinicians in NYS..